NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
- PMID: 27853380
- PMCID: PMC5106235
- DOI: 10.2147/OTT.S109606
NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
Abstract
Recently, the human gene NOTCH1 has been found to be implicated in cancer cell metastasis and the maintenance of cancer stem cells. However, for breast cancer in particular, an association between NOTCH1 levels and metastasis has not been determined. In this study, we investigated the expression status and correlation of NOTCH1 with clinically important factors related to metastasis and the cancer stem cell marker ALDH1. NOTCH1 and ALDH1 levels in 115 tumor tissues from primary lesions were determined by immunohistochemical staining. Most tissues were stained positive for both NOTCH1 and ALDH1, and NOTCH1 positivity was significantly associated with ALDH1 levels. NOTCH1 levels were significantly associated with TNM stage, metastasis, and triple-negative breast cancer. Moreover, both univariate and multivariate regression analyses revealed that basal-like features and NOTCH1 positivity were associated with disease-free survival as independent predictors. These analyses indicated that breast cancer patients testing positive for NOTCH1 had shorter disease-free survival. Our findings suggest that NOTCH1 may be involved in metastasis and is closely correlated with breast cancer stem cells.
Keywords: ALDH1; NOTCH1; breast cancer; cancer stem cell; metastasis.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.J Gastrointest Cancer. 2019 Dec;50(4):824-837. doi: 10.1007/s12029-018-0156-6. J Gastrointest Cancer. 2019. PMID: 30136202
-
Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb. Pathology. 2012. PMID: 22544210
-
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.Breast Cancer Res. 2016 Jul 2;18(1):73. doi: 10.1186/s13058-016-0731-3. Breast Cancer Res. 2016. PMID: 27368476 Free PMC article.
-
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.J Breast Cancer. 2015 Dec;18(4):347-55. doi: 10.4048/jbc.2015.18.4.347. Epub 2015 Dec 23. J Breast Cancer. 2015. PMID: 26770241 Free PMC article.
-
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.PLoS One. 2015 Dec 18;10(12):e0145164. doi: 10.1371/journal.pone.0145164. eCollection 2015. PLoS One. 2015. PMID: 26682730 Free PMC article. Review.
Cited by
-
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype.J Oncol. 2019 Jul 11;2019:8707053. doi: 10.1155/2019/8707053. eCollection 2019. J Oncol. 2019. PMID: 31379945 Free PMC article. Review.
-
Obesity-Altered Adipose Stem Cells Promote Radiation Resistance of Estrogen Receptor Positive Breast Cancer through Paracrine Signaling.Int J Mol Sci. 2020 Apr 15;21(8):2722. doi: 10.3390/ijms21082722. Int J Mol Sci. 2020. PMID: 32326381 Free PMC article.
-
Breast Cancer Stem Cells.Biomedicines. 2018 Jul 17;6(3):77. doi: 10.3390/biomedicines6030077. Biomedicines. 2018. PMID: 30018256 Free PMC article. Review.
-
Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.Stem Cells Int. 2017;2017:2925869. doi: 10.1155/2017/2925869. Epub 2017 Mar 5. Stem Cells Int. 2017. PMID: 28356914 Free PMC article. Review.
-
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer.Oncol Res. 2022 Dec 6;30(1):35-51. doi: 10.32604/or.2022.026616. eCollection 2022. Oncol Res. 2022. PMID: 37304008 Free PMC article.
References
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. - PubMed
-
- Prager GW, Poettler M. Angiogenesis in cancer: basic mechanisms and therapeutic advances. Hamostaseologie. 2012;32(2):105–114. - PubMed
-
- Bridges E, Oon CE, Harris A. Notch regulation of tumor angiogenesis. Future Oncol. 2011;7(4):569–588. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
